| Autor: |
Jeannie Callum, Yulia Lin, Katherine Wilkinson, Stephanie Poon, Mena Gewarges, Roslyn Mainland, Jaime Sklar, Andrew Gentilin, Bianca McLean, Omar I Hajjaj, Mali Worme, Spencer Lalonde, Raumil Patel |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
BMJ Open Quality, Vol 13, Iss 1 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2399-6641 |
| DOI: |
10.1136/bmjoq-2023-002584 |
| Popis: |
Introduction Iron deficiency anaemia (IDA) is common in patients with heart failure (HF) and is associated with advanced HF and increased mortality. Intravenous iron supplementation increases exercise tolerance, improves quality of life, and decreases symptoms among patients with HF with reduced ejection fraction (HFrEF) and iron deficiency. Despite this, many patients are not screened or treated for IDA. We aimed to increase rates of screening and treatment of IDA among HF patients through the introduction of curated materials to aid HF clinicians with appropriate screening and treatment.Methods We conducted a retrospective chart review to identify the baseline number of HFrEF patients screened and treated for IDA at two ambulatory cardiology clinics in Toronto, Ontario. A quality improvement initiative was then introduced, which consisted of education and curated materials to aid clinicians in the screening and treatment of IDA among HFrEF patients. The proportion of patients screened and treated for IDA preintervention and postintervention were compared using χ2 tests of Independence.Results In the preintervention cohort, 36.3% (n=45) of patients with anaemia were screened for IDA. Among those screened, 64.4% (n=29) had IDA. Only 17.2% (n=5) of these were treated with IV iron. After implementation of the quality improvement initiative, 90.9% (n=60) of patients with anaemia were screened for IDA (p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
